Tetra Pharm Technologies Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 55

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.26M

  • Investors
  • 2

Tetra Pharm Technologies General Information

Description

Operator of a biopharmaceutical company intended to deliver cannabinoid-based therapies. The company specializes in the development of pharmaceutical drugs aimed at the central nervous system and the immune system and offers a suite of tailored end-to-end contract development and manufacturing services, enabling healthcare industries to treat neurological diseases and mental health disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ørestads Boulevard 108
  • 2300 Copenhagen
  • Denmark
+45 60
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Services
Vertical(s)
Corporate Office
  • Ørestads Boulevard 108
  • 2300 Copenhagen
  • Denmark
+45 60

Tetra Pharm Technologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tetra Pharm Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 12-Apr-2024 $7.26M Completed Generating Revenue
3. Early Stage VC (Series A) 26-Jan-2023 Completed Startup
2. Early Stage VC 08-Feb-2022 $1.53M $3.81M Completed Startup
1. Seed Round 15-Dec-2021 $2.28M $2.28M Completed Startup
To view Tetra Pharm Technologies’s complete valuation and funding history, request access »

Tetra Pharm Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 2,564 $570.32 $570.32 1x $570.32 3.79%
Ordinary 8,076 $270.07 $270.07 1x $270.07 11.95%
To view Tetra Pharm Technologies’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tetra Pharm Technologies Patents

Tetra Pharm Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026037496-A1 A self-emulsifying solid composition comprising a cannabinoid Pending 14-Aug-2024
WO-2024165166-A1 A cannabinoid-based o/w emulsification system for oral administration targeting endocannabinoid receptors Inactive 10-Feb-2023
WO-2024165165-A1 A cannabinoid-based o/w emulsification system for sublingual and buccal administration targeting endocannabinoid receptors Inactive 10-Feb-2023
EP-4493154-A1 A cannabinoid-based oil-in-water emulsion for sublingual and buccal administration Pending 10-Feb-2023
WO-2024165731-A1 A cannabinoid-based oil-in-water emulsion for sublingual and buccal administration Inactive 10-Feb-2023 A61K9/1075
To view Tetra Pharm Technologies’s complete patent history, request access »

Tetra Pharm Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tetra Pharm Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enexis (Sweden) Venture Capital Minority
Leafy Tunnel Venture Capital Minority
To view Tetra Pharm Technologies’s complete investors history, request access »

Tetra Pharm Technologies FAQs

  • When was Tetra Pharm Technologies founded?

    Tetra Pharm Technologies was founded in 2019.

  • Where is Tetra Pharm Technologies headquartered?

    Tetra Pharm Technologies is headquartered in Copenhagen, Denmark.

  • What is the size of Tetra Pharm Technologies?

    Tetra Pharm Technologies has 55 total employees.

  • What industry is Tetra Pharm Technologies in?

    Tetra Pharm Technologies’s primary industry is Pharmaceuticals.

  • Is Tetra Pharm Technologies a private or public company?

    Tetra Pharm Technologies is a Private company.

  • What is the current valuation of Tetra Pharm Technologies?

    The current valuation of Tetra Pharm Technologies is .

  • What is Tetra Pharm Technologies’s current revenue?

    The current revenue for Tetra Pharm Technologies is .

  • How much funding has Tetra Pharm Technologies raised over time?

    Tetra Pharm Technologies has raised $20.5M.

  • Who are Tetra Pharm Technologies’s investors?

    Enexis (Sweden) and Leafy Tunnel have invested in Tetra Pharm Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process